Observational studies indicate that children hospitalized with COVID‐19‐related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children… Click to show full abstract
Observational studies indicate that children hospitalized with COVID‐19‐related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children hospitalized with COVID‐19‐related illness has recently been initiated in the United States. To date, there remains a paucity of high‐quality evidence to inform clinical practice world‐wide. Therefore, the objective of this scientific statement is to provide consensus‐based recommendations on the use of anticoagulant thromboprophylaxis in children hospitalized for COVID‐19‐related illnesses, and to identify priorities for future research.
               
Click one of the above tabs to view related content.